In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Alpelisib Drug Master File in Korea (Alpelisib KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Alpelisib. The MFDS reviews the Alpelisib KDMF as part of the drug registration process and uses the information provided in the Alpelisib KDMF to evaluate the safety and efficacy of the drug.
After submitting a Alpelisib KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Alpelisib API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Alpelisib suppliers with KDMF on PharmaCompass.